ANG

angiogenin, the group of Ribonuclease A family|Endoribonucleases

Basic information

Region (hg38): 14:20684177-20698971

Links

ENSG00000214274NCBI:283OMIM:105850HGNC:483Uniprot:P03950AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • amyotrophic lateral sclerosis type 9 (Strong), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 9 (Definitive), mode of inheritance: AD
  • amyotrophic lateral sclerosis (Supportive), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 9 (Strong), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 9 (Limited), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Amyotrophic lateral sclerosis 9ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic15557516; 16501576; 17886298; 18087731; 18852347; 19153377; 20577002

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANG gene.

  • not_provided (54 variants)
  • Amyotrophic_lateral_sclerosis_type_9 (24 variants)
  • Inborn_genetic_diseases (18 variants)
  • ANG-related_disorder (11 variants)
  • not_specified (6 variants)
  • Frontotemporal_dementia (1 variants)
  • Amyotrophic_lateral_sclerosis_type_10 (1 variants)
  • Amyotrophic_lateral_sclerosis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANG gene is commonly pathogenic or not. These statistics are base on transcript: NM_001097577.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
15
clinvar
15
missense
6
clinvar
2
clinvar
44
clinvar
6
clinvar
1
clinvar
59
nonsense
0
start loss
1
1
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
0
Total 6 2 47 21 1

Highest pathogenic variant AF is 0.000017967

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANGprotein_codingprotein_codingENST00000336811 114795
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.2870.50100000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.07778385.00.9760.00000536952
Missense in Polyphen2226.470.83113322
Synonymous0.3243234.40.9300.00000207306
Loss of Function0.23900.06680.002.76e-93

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to actin on the surface of endothelial cells; once bound, angiogenin is endocytosed and translocated to the nucleus. Stimulates ribosomal RNA synthesis including that containing the initiation site sequences of 45S rRNA. Cleaves tRNA within anticodon loops to produce tRNA-derived stress-induced fragments (tiRNAs) which inhibit protein synthesis and triggers the assembly of stress granules (SGs). Angiogenin induces vascularization of normal and malignant tissues. Angiogenic activity is regulated by interaction with RNH1 in vivo. {ECO:0000269|PubMed:12051708, ECO:0000269|PubMed:1400510, ECO:0000269|PubMed:19354288, ECO:0000269|PubMed:21855800}.;
Disease
DISEASE: Amyotrophic lateral sclerosis 9 (ALS9) [MIM:611895]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269|PubMed:15557516, ECO:0000269|PubMed:16501576, ECO:0000269|PubMed:17703939, ECO:0000269|PubMed:17886298, ECO:0000269|PubMed:17900154, ECO:0000269|PubMed:18087731, ECO:0000269|PubMed:22292843, ECO:0000269|PubMed:25372031}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Cell-cell junction organization;Adherens junctions interactions;Cell junction organization;Cell-Cell communication (Consensus)

Intolerance Scores

loftool
rvis_EVS
0.24
rvis_percentile_EVS
68.98

Haploinsufficiency Scores

pHI
0.190
hipred
N
hipred_score
0.146
ghis
0.406

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowMedium
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ang
Phenotype

Gene ontology

Biological process
angiogenesis;ovarian follicle development;oocyte maturation;response to hypoxia;placenta development;positive regulation of endothelial cell proliferation;diacylglycerol biosynthetic process;cell communication;activation of phospholipase C activity;rRNA transcription;response to hormone;cell migration;negative regulation of translation;actin filament polymerization;activation of protein kinase B activity;activation of phospholipase A2 activity;adherens junction organization;positive regulation of phosphorylation;homeostatic process;negative regulation of smooth muscle cell proliferation;positive regulation of protein secretion;RNA phosphodiester bond hydrolysis
Cellular component
extracellular region;basement membrane;extracellular space;nucleus;nucleolus;growth cone;cytoplasmic vesicle;angiogenin-PRI complex;neuronal cell body
Molecular function
DNA binding;actin binding;endonuclease activity;ribonuclease activity;signaling receptor binding;copper ion binding;protein binding;heparin binding;rRNA binding;peptide binding;protein homodimerization activity